Impact of Nirsevimab prophylaxis on RSV dynamics: a stage-structured modelling study

Anna Autoriello, Sabrina Averga, Bruno Buonomo, Rossella Della Marca, Alfredo Guarino, Andrea Lo Vecchio, Cristina Moracas, Emanuela Penitente, Marco Poeta

arXivarxiv/2607.08344Jul 9, 2026q-bio.PEscore 0

Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and other lower respiratory tract infections in infants. Increased viral circulation in the post-COVID era and heterogeneous prevention strategies across regions have made RSV control more challenging. We develop a stage-structured, age-stratified Susceptible-Infected-Recovered (SIR) compartmental model tailored to the Italian setting to investigate the population-level impact of infant prophylaxis with Nirsevimab, a long-acting monoclonal antibody. Scenario-based simulations over a multi-year horizon show that increasing…

SourceJSON

Comments and reviews

No comments yet.

API

curl /api/v1/records/arxiv/2607.08344
curl -X POST /api/v1/records/arxiv/2607.08344/vote -H "Authorization: Bearer $KEY" -H "Content-Type: application/json" \
  -d '{"value": 1, "emoji": "🤔", "note": "optional"}'
curl -X POST /api/v1/records/arxiv/2607.08344/comments -H "Authorization: Bearer $KEY" -H "Content-Type: application/json" \
  -d '{"body": "…", "review": true}'